NBI-5788, an altered MBP83-99 peptide, induces a T-helper 2-like immune response in multiple sclerosis patients

Annals of Neurology

Volumn 48, Issue 5, 2000, Pages 758-765

  Crowe, Paul D ^a   Qin, Yufen ^b   Conlon, Paul J ^a   Antel, Jack P ^b  

^a NEUROCRINE BIOSCIENCES INC   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN BASIC PROTEIN; TIPLIMOTIDE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CLINICAL LABORATORY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; TH2 CELL;

ADULT; ANTIBODY SPECIFICITY; CYTOKINES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0033762708     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200011)48:5<758::AID-ANA9>3.0.CO;2-2     Document Type: Article

References (22)

1. Immunological aspects of demyelinating diseases
2. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system
3. The T lymphocyte in experimental allergic encephalomyelitis
4. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals
5. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis
6. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals
7. Encephalitogenic epitopes of myelin basic protein
8. Peptide-major histocompatibility complex class II complexes with mixed agonist/ antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling
9. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand
10. + T cells
11. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides
12. Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms
13. Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7
14. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species
15. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: Growth hormone-releasing factor
16. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma
17. T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes
18. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
19. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein
20. A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens
21. Double-blind randomized placebo control parallel-group evaluation of the safety and effect on immunological parameters of the altered peptide ligand MSP771 in patients with MS
22. Antigen-specific immunomodulation confirms the encephalitogenic potential of myelin basic protein peptide (83-99) in multiple sclerosis